397 related articles for article (PubMed ID: 25193090)
1. Chordoma: the entity.
Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
[TBL] [Abstract][Full Text] [Related]
2. The molecular aspects of chordoma.
Gulluoglu S; Turksoy O; Kuskucu A; Ture U; Bayrak OF
Neurosurg Rev; 2016 Apr; 39(2):185-96; discussion 196. PubMed ID: 26363792
[TBL] [Abstract][Full Text] [Related]
3. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
4. From notochord formation to hereditary chordoma: the many roles of Brachyury.
Nibu Y; José-Edwards DS; Di Gregorio A
Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285
[TBL] [Abstract][Full Text] [Related]
5. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
[TBL] [Abstract][Full Text] [Related]
6. Tumor-biology and current treatment of skull-base chordomas.
Pamir MN; Ozduman K
Adv Tech Stand Neurosurg; 2008; 33():35-129. PubMed ID: 18383812
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic targets in chordoma.
Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
[TBL] [Abstract][Full Text] [Related]
8. Chordoma: the nonsarcoma primary bone tumor.
Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
Alholle A; Brini AT; Bauer J; Gharanei S; Niada S; Slater A; Gentle D; Maher ER; Jeys L; Grimer R; Sumathi VP; Latif F
Epigenetics; 2015; 10(3):213-20. PubMed ID: 25621392
[TBL] [Abstract][Full Text] [Related]
10. Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.
Yamaguchi T; Imada H; Iida S; Szuhai K
Surg Pathol Clin; 2017 Sep; 10(3):637-656. PubMed ID: 28797506
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin.
Kikuchi Y; Yamaguchi T; Kishi H; Azuhata K; Kimizuka G; Hiroshima K; Nakatani Y
Am J Surg Pathol; 2011 Aug; 35(8):1158-64. PubMed ID: 21716081
[TBL] [Abstract][Full Text] [Related]
12. [From bench to bedside for new treatment paradigms in chordomas: An update].
Méry B; Rowinski E; Guinand M; Benna M; Bousarsar A; Bosacki C; Vallard A; Magné N
Bull Cancer; 2020 Jan; 107(1):129-135. PubMed ID: 31882268
[TBL] [Abstract][Full Text] [Related]
13. Chordoma: current concepts, management, and future directions.
Walcott BP; Nahed BV; Mohyeldin A; Coumans JV; Kahle KT; Ferreira MJ
Lancet Oncol; 2012 Feb; 13(2):e69-76. PubMed ID: 22300861
[TBL] [Abstract][Full Text] [Related]
14. Chordomas: A review with emphasis on their pathophysiology, pathology, molecular biology, and genetics.
Karpathiou G; Dumollard JM; Dridi M; Dal Col P; Barral FG; Boutonnat J; Peoc'h M
Pathol Res Pract; 2020 Sep; 216(9):153089. PubMed ID: 32825957
[TBL] [Abstract][Full Text] [Related]
15. Atypical Notochordal Cell Tumors: A Series of Notochordal-derived Tumors That Defy Current Classification Schemes.
Carter JM; Wenger DE; Rose PS; Inwards CY
Am J Surg Pathol; 2017 Jan; 41(1):39-48. PubMed ID: 27819871
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment.
Baluszek S; Kober P; Rusetska N; Wągrodzki M; Mandat T; Kunicki J; Bujko M
Acta Neuropathol Commun; 2023 Jul; 11(1):113. PubMed ID: 37434245
[TBL] [Abstract][Full Text] [Related]
17. Hand metastasis from a sacral chordoma.
Emori M; Kaya M; Sugita S; Soma T; Sasaki M; Yamashita T
Ann R Coll Surg Engl; 2014 Nov; 96(8):e8-11. PubMed ID: 25350167
[TBL] [Abstract][Full Text] [Related]
18. Advances in the development of chordoma models for drug discovery and precision medicine.
Walker RL; Hornicek FJ; Duan Z
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188812. PubMed ID: 36195275
[TBL] [Abstract][Full Text] [Related]
19. Skull base chordomas review of current treatment paradigms.
Yaniv D; Soudry E; Strenov Y; Cohen MA; Mizrachi A
World J Otorhinolaryngol Head Neck Surg; 2020 Jun; 6(2):125-131. PubMed ID: 32596658
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of histopathological parameters, genome-wide copy number alterations, and variants in genes involved in cell cycle regulation in chordomas of the skull base and sacrum.
Salle H; Durand S; Durand K; Bourthoumieu S; Lemnos L; Robert S; Pollet J; Passeri T; Khalil W; Froelich S; Adle-Biassette H; Labrousse F
J Neuropathol Exp Neurol; 2023 Mar; 82(4):312-323. PubMed ID: 36779322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]